June 26, 2009 > Although NICE has been labeled “un-American,” the U.S. may end up with an entity like it to oversee the comparative effectiveness research mandated by the stimulus legislation. However, such a body in the U.S. would not in fact be “NICER,” because it would fail to take cost into account, make clinical recommendations, or do little more than disseminate technical reports. read more »